Canadian Nephrology Trials Network announces committee membership

2019-04-01T16:12:46+00:00April 1, 2019|Tags: |

The Canadian Nephrology Trials Network (CNTN) is a pan-Canadian bilingual network of research nephrologists that was initially established to foster the design and conduct of multi-centre, prospective research, particularly randomized controlled trials, in nephrology. There is membership from researchers in all regions of Canada and it has extended membership to patient partners from across Canada, including Indigenous communities.

Based on the outcome of a visioning workshop in September 2018, the CNTN will now include 3 working committees – Capacity Building, Communication and Engagement, and Scientific Operations – as well as a governing Executive Committee. The Executive Committee co-chairs will be responsible for reporting to the Can-SOLVE CKD Steering Committee.

We have received a number of expressions of interest to take on leadership roles within the new structure of the CNTN. These have been carefully reviewed and vetted by the Can-SOLVE CKD leadership team, taking into account the need for a representative executive committee, inclusive of patient partners. The leadership team considered skill sets, experience, diversity and competing commitments and is pleased to announce the new committee roles.

We would like to express our heartfelt thanks to the current members of the CNTN Executive Committee, who have led CNTN through this period of transition. We are grateful for your time and guidance in moving CNTN forward.

Latest News